MX386552B - Parche que comprende permanganato de potasio para el tratamiento de trastorno de la piel. - Google Patents

Parche que comprende permanganato de potasio para el tratamiento de trastorno de la piel.

Info

Publication number
MX386552B
MX386552B MX2019003347A MX2019003347A MX386552B MX 386552 B MX386552 B MX 386552B MX 2019003347 A MX2019003347 A MX 2019003347A MX 2019003347 A MX2019003347 A MX 2019003347A MX 386552 B MX386552 B MX 386552B
Authority
MX
Mexico
Prior art keywords
treatment
potassium permanganate
skin disorders
containing potassium
patch containing
Prior art date
Application number
MX2019003347A
Other languages
English (en)
Other versions
MX2019003347A (es
Inventor
Charles Heard
David Houston
Keith Harding
Original Assignee
Onya Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onya Therapeutics Ltd filed Critical Onya Therapeutics Ltd
Publication of MX2019003347A publication Critical patent/MX2019003347A/es
Publication of MX386552B publication Critical patent/MX386552B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La invención se refiere a un parche de tratamiento médico, idealmente para aplicación tópica, que permite la liberación dirigida, sostenida y controlada de potasio KMnO4; y un método para tratar un trastorno cutáneo que comprende aplicar dicho parche.
MX2019003347A 2016-09-23 2017-09-21 Parche que comprende permanganato de potasio para el tratamiento de trastorno de la piel. MX386552B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1616223.2A GB201616223D0 (en) 2016-09-23 2016-09-23 Topical treatment patch
PCT/GB2017/052816 WO2018055376A1 (en) 2016-09-23 2017-09-21 Patch comprising potassium permanganate for the treatment of skin disorder

Publications (2)

Publication Number Publication Date
MX2019003347A MX2019003347A (es) 2019-10-07
MX386552B true MX386552B (es) 2025-03-11

Family

ID=57539902

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003347A MX386552B (es) 2016-09-23 2017-09-21 Parche que comprende permanganato de potasio para el tratamiento de trastorno de la piel.

Country Status (18)

Country Link
US (1) US11129800B2 (es)
EP (1) EP3515416B1 (es)
JP (1) JP7066692B2 (es)
KR (1) KR102552765B1 (es)
CN (1) CN109982688B (es)
AU (1) AU2017332832B2 (es)
DK (1) DK3515416T3 (es)
ES (1) ES2954142T3 (es)
GB (1) GB201616223D0 (es)
HU (1) HUE063088T2 (es)
IL (1) IL265581B2 (es)
MX (1) MX386552B (es)
MY (1) MY200120A (es)
PL (1) PL3515416T3 (es)
PT (1) PT3515416T (es)
RU (1) RU2770064C2 (es)
WO (1) WO2018055376A1 (es)
ZA (1) ZA201902228B (es)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3839246A (en) * 1973-08-09 1974-10-01 Gen Electric Two-part room temperature vulcanizable systems
GB1412970A (en) 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
JPS59104314A (ja) * 1982-11-09 1984-06-16 Hisamitsu Pharmaceut Co Inc 新規貼付薬
JP2659961B2 (ja) * 1986-08-18 1997-09-30 中外製薬株式会社 経皮吸収貼付剤
US5792090A (en) * 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
JPH10158155A (ja) * 1996-11-29 1998-06-16 Tac Medical Kk 貼付剤
CA2445086C (en) * 2001-05-01 2008-04-08 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US20030180281A1 (en) 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
JP2004321785A (ja) 2003-04-07 2004-11-18 Ube Ind Ltd 医療用パッチ及びその製造方法
KR20070007299A (ko) * 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
CA2596529C (en) * 2005-01-27 2014-08-19 Corium International, Inc. Hydrophilic biocompatible adhesive formulations and uses
JP2006248996A (ja) 2005-03-10 2006-09-21 Nitto Denko Corp 経皮吸収型貼付剤
DE102006025282A1 (de) * 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
US20150141389A1 (en) 2012-04-27 2015-05-21 Dow Corning Corporation Topical Formulation Compositions Containing Silicone Based Excipients To Deliver Actives To A Substrate
CN103819799B (zh) * 2014-03-07 2016-02-24 福州大学 一种聚合物/高锰酸钾复合薄膜及其制备方法
US20180036450A1 (en) * 2015-02-16 2018-02-08 Ctm@Crc Ltd. Methods and products for delivering cells
EP3446693B1 (en) * 2015-02-19 2020-11-11 Hiantis S.r.l. Pharmaceutical compositions and formulations comprising aluminium acetate for topical application with astringent and antimicrobial effect
CA2928330C (en) * 2015-04-28 2021-08-17 Frank Dicosmo Antimicrobial silicone adhesive dressings comprising phmb and edta

Also Published As

Publication number Publication date
RU2019112100A (ru) 2020-10-23
IL265581B2 (en) 2023-04-01
GB201616223D0 (en) 2016-11-09
BR112019005722A2 (pt) 2019-07-09
WO2018055376A1 (en) 2018-03-29
MY200120A (en) 2023-12-08
DK3515416T3 (da) 2023-09-04
IL265581A (en) 2019-05-30
JP7066692B2 (ja) 2022-05-13
EP3515416A1 (en) 2019-07-31
KR102552765B1 (ko) 2023-07-10
BR112019005722A8 (pt) 2023-04-11
KR20190080869A (ko) 2019-07-08
IL265581B (en) 2022-12-01
ZA201902228B (en) 2022-12-21
EP3515416B1 (en) 2023-06-07
RU2770064C2 (ru) 2022-04-14
HUE063088T2 (hu) 2023-12-28
US20190224133A1 (en) 2019-07-25
ES2954142T3 (es) 2023-11-20
CA3037807A1 (en) 2018-03-29
PT3515416T (pt) 2023-09-07
CN109982688A (zh) 2019-07-05
US11129800B2 (en) 2021-09-28
JP2019533648A (ja) 2019-11-21
RU2019112100A3 (es) 2020-12-11
CN109982688B (zh) 2023-08-15
MX2019003347A (es) 2019-10-07
AU2017332832B2 (en) 2023-04-27
PL3515416T3 (pl) 2024-01-15
AU2017332832A1 (en) 2019-04-18

Similar Documents

Publication Publication Date Title
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
CL2019000979A1 (es) Composiciones y anticuerpos anti-lag-3.
CL2018003207A1 (es) Procedimientos para tratar cancer de piel a traves de la administración de un inhibidor pd-1.
CL2018002359A1 (es) Métodos para usar agonistas de fxr
CL2016001715A1 (es) Nuevos inhibidores de glutaminasa
MX2017010773A (es) Inhibidores de muerte programada 1 (pd-19)/ligando de muerte progamada 1 (pd-l1) para el tratamiento de cancer.
CO2017005034A2 (es) Tratamiento de convulsiones con fosfatasa alcalina recombinante
MX2016014140A (es) Composiciones y metodos para modular la expresion de pkk.
MX2021006734A (es) Metodo para tratar el cancer.
BR112019005226A2 (pt) sistema de cateter para tratar doenças vasculares e não vasculares
MX370506B (es) Método para tratar trastorno de estrés post-traumático.
BR112016023815A2 (pt) composições tópicas para o alívio da dor, produção e uso
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
MX388890B (es) Metodos para tratar cancer usando compuestos de pirimidina y piridina con actividad inhibidora de tirosina cinasa de bruton.
MX2018003174A (es) Metodos para tratar enfermedades inflamatorias.
MX386146B (es) Métodos para tratar esclerosis múltiple usando compuestos de pirimidina y piridina con actividad inhibidora de tirosina cinasa de bruton.
MX2019003069A (es) Uso de pridopidina para tratar el sindrome de rett.
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
MX2018014938A (es) Combinaciones farmaceuticas para el tratamiento del cancer.
BR112018075039A2 (pt) métodos de tratamento da síndrome de prader-willi
MX2018012230A (es) Métodos para tratar enfermedades oculares.
MX2018000274A (es) Bacterias oxidantes de amoniaco para el tratamiento del acne.
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
MX2017005064A (es) Metodos para tratar afecciones oculares.
MX2020005952A (es) Uso de mir101 o mir128 en el tratamiento de trastornos convulsivos.